Topic: Drug Development Forum
The public markets have been receptive to early-stage biotechs but will the IPO remain open? We asked our Fierce 15 winners what they thought.
As part of our video series for this year’s DDF 2017 event, life science leaders spoke to us about CRO needs and new regulations.
After announcing this year’s Fierce 15 winners, we invited their executives to the Drug Development Forum in Boston to discuss some of the pivotal moments leading up to their win.
Biopharma executives share how they manage outsourcing relationships at this year's Drug Development Forum.